Merck KGAA (PK) Quote - MKGAF

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

143.70

Bid

140.03

Ask

153.92

Volume

184

143.70 Day's Range 150.10

140.005 52 Week Range 200.56

Market Cap

18.572B

Previous Close

145.65

Open

150.10

Last Trade

143.7

Last Trade Time

Financial Volume

US$ 27,410

VWAP

148.9683

Average Volume (3m)

1,027

Shares Outstanding

129,242,251

Dividend Yield

1.48%

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

20.99B

Net Profit

2.82B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Diversified

Website

www.merck.de

Headquarters

Darmstadt, Deu

Founded

1987

Merck KGAA (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker MKGAF. The last closing price for Merck KGAA (PK) was US$145.65. Over the last year, Merck KGAA (PK) shares have traded in a share price range of US$ 140.005 to US$ 200.56.

Merck KGAA (PK) currently has 129,242,251 shares outstanding. The market capitalization of Merck KGAA (PK) is US$18.82 billion.

Data on Merck KGaA's L-BLP25 - Analyst Blog

Merck KGaA (MKGAF ) recently presented detailed results on its oncology candidate L-BLP25, from the phase III study, START (Stimulating Targeted Antigenic Responses To NSCLC). Results...

Merck KGaA Posts Higher Y/Y Earnings - Analyst Blog

Merck KGaA (MKGAF) reported first quarter 2013 earnings per American Depositary Receipt (ADR) of $2.79, up 28.1% year over year. Revenues for the reported quarter were up 4.4% year over year...

Merck KGaA-CBRX Renew Agreement - Analyst Blog

Merck KGaA (MKGAF) and Columbia Laboratories, Inc. (CBRX) recently renewed a license and supply agreement for Crinone (progesterone gel), extending it for an additional five years. This...

Sanofi Reports Lemtrada Data - Analyst Blog

Sanofi’s (SNY) subsidiary, Genzyme, recently announced interim data on its multiple sclerosis (MS) candidate, Lemtrada (alemtuzumab), from the first year of an extension study. ...

Merck KGaA-BMY Collaborate - Analyst Blog

Merck KGaA (MKGAF) recently announced a deal with Bristol-Myers Squibb (BMY) for the promotion of different formulations of Glucophage (metformin hydrochloride) in China. Glucophage is used for...

Merck KGaA - Nordic Bioscience Collaborate - Analyst Blog

Merck KGaA (MKGAF) recently announced a strategic deal with Nordic Bioscience Clinical Development A/S for its pipeline candidate, sprifermin (recombinant human FGF-18). Sprifermin is being...

Threshold Cuts Loss, Misses Sales - Analyst Blog

Threshold Pharmaceuticals Inc. (THLD) reported fourth-quarter 2012 net loss per share of 10 cents, narrower than the Zacks Consensus Estimate of a loss of 12 cents and the year-ago loss of 11...

Strong Quarter for Merck KGaA - Analyst Blog

Merck KGaA (MKGAF) reported fourth quarter 2012 earnings per American Depository Receipt (ADR) of $2.66, up 18.8% year over year. Revenues for the reported quarter were up 8% year over year...

Positive Data from BMRN's PKU-016 - Analyst Blog

BioMarin Pharmaceutical Inc. (BMRN) recently announced positive results from the PKU-016 ASCEND study. This is the largest randomized controlled study evaluating the safety and therapeutic...

Threshold/Merck KGaA Drug in Study - Analyst Blog

Threshold Pharmaceuticals, Inc. (THLD) and Merck KGaA (MKGAF) recently announced the commencement of a global phase III study (MAESTRO) on their hypoxia-targeted candidate, TH-302. The study...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-11.05	-7.14054927302	154.75	155.75	143.7	123	149.69154472	CS
4	-0.848	-0.586656335612	144.548	159.75	141.811	1095	146.1182879	CS
12	-8.3	-5.46052631579	152	159.75	140.005	1027	146.40247966	CS
26	-34.576	-19.3946465032	178.276	200.56	140.005	557	150.87701877	CS
52	-16.941	-10.5458755859	160.641	200.56	140.005	542	161.10779669	CS
156	-74.125	-34.0296109262	217.825	225.89	140.005	676	170.23046598	CS
260	12.85	9.82040504394	130.85	264.4	82	636	158.17016702	CS

MKGAF - Frequently Asked Questions (FAQ)

What is the current Merck KGAA (PK) share price?

The current share price of Merck KGAA (PK) is US$ 143.70

How many Merck KGAA (PK) shares are in issue?

Merck KGAA (PK) has 129,242,251 shares in issue

What is the market cap of Merck KGAA (PK)?

The market capitalisation of Merck KGAA (PK) is USD 18.82B

What is the 1 year trading range for Merck KGAA (PK) share price?

Merck KGAA (PK) has traded in the range of US$ 140.005 to US$ 200.56 during the past year

What is the reporting currency for Merck KGAA (PK)?

Merck KGAA (PK) reports financial results in EUR

What is the latest annual turnover for Merck KGAA (PK)?

The latest annual turnover of Merck KGAA (PK) is EUR 20.99B

What is the latest annual profit for Merck KGAA (PK)?

The latest annual profit of Merck KGAA (PK) is EUR 2.82B

What is the registered address of Merck KGAA (PK)?

The registered address for Merck KGAA (PK) is FRANKFURTER STRASSE 250, DARMSTADT, 64293

What is the Merck KGAA (PK) website address?

The website address for Merck KGAA (PK) is www.merck.de

Which industry sector does Merck KGAA (PK) operate in?

Merck KGAA (PK) operates in the PHARMACEUTICAL DIVERSIFIED sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SHWZMedicine Man Technologies Inc (CE)	US$ 0.0011 (109,900.00%)	530
ZHCLFZenith Capital Corporation (CE)	US$ 0.10 (99,900.00%)	6k
GNCAQGenocea Biosciences Inc (CE)	US$ 0.0005 (49,900.00%)	2k
CCTLCoin Citadel (PK)	US$ 0.0002 (19,900.00%)	509.6k
TPTWTPT Global Tech Inc (CE)	US$ 0.0002 (19,900.00%)	25.08M
BRGOBergio International Inc (PK)	US$ 0.000001 (-99.00%)	502k
POLCQPolished Inc (CE)	US$ 0.000001 (-99.00%)	130
PUGEPuget Technologies Inc (CE)	US$ 0.000001 (-99.00%)	169k
COSGCosmos Group Holdings Inc (PK)	US$ 0.000001 (-99.00%)	10M
RNWFRenewal Fuels Inc (CE)	US$ 0.000001 (-99.00%)	133
IMTLImage Protect Inc (PK)	US$ 0.0001 (-33.33%)	289.87M
ABQQAB International Group Corporation (PK)	US$ 0.0003 (-25.00%)	286.78M
PDGOParadigm Oil and Gas Inc (PK)	US$ 0.0001 (0.00%)	225.08M
BOMObowmo Inc (PK)	US$ 0.0005 (66.67%)	211.25M
RONNRonn Motor Group Inc (PK)	US$ 0.0003 (0.00%)	187.29M